{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:19:51Z","timestamp":1759479591518},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T00:00:00Z","timestamp":1261094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00277-009-0885-5","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T07:59:09Z","timestamp":1261036749000},"page":"613-618","source":"Crossref","is-referenced-by-count":20,"title":["CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence"],"prefix":"10.1007","volume":"89","author":[{"given":"Patrizia","family":"Piccioli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Balbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Lamparelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Dozin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Bruzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Ferraris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bacigalupo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Notaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Pia","family":"Pistillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,18]]},"reference":[{"key":"885_CR1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/1074-7613(94)90071-X","volume":"1","author":"TL Walunas","year":"1994","unstructured":"Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CB, Bluestone JA (1994) CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405\u2013413","journal-title":"Immunity"},{"key":"885_CR2","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1126\/science.282.5397.2263","volume":"282","author":"KM Lee","year":"1998","unstructured":"Lee KM, Chuang E, Griffin M, Khattri R, Hong DK, Zhang W, Straus D, Samelson LE, Thompson CB, Bluestone JA (1998) Molecular basis of T cell inactivation by CTLA-4. Science 282:2263\u20132266","journal-title":"Science"},{"key":"885_CR3","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.4049\/jimmunol.169.7.3744","volume":"169","author":"M Sho","year":"2002","unstructured":"Sho M, Yamada A, Najafian N, Salama AD, Harada H, Sandner SE, Sanchez-Fueyo A, Zheng XX, Strom TB, Sayegh MH (2002) Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size. J Immunol 169:3744\u20133751","journal-title":"J Immunol"},{"key":"885_CR4","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.4049\/jimmunol.174.11.6648","volume":"174","author":"T Ito","year":"2005","unstructured":"Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H Jr, Sayegh MH, Najafian N (2005) Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. J Immunol 174:6648\u20136656","journal-title":"J Immunol"},{"key":"885_CR5","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/sj.leu.2404720","volume":"21","author":"S Fevery","year":"2007","unstructured":"Fevery S, Billiau AD, Sprangers B, Rutgeerts O, Lenaerts C, Goebels J, Landuyt W, Kasran A, Boon L, Sagaert X, De Wolf-Peeters C, Waer M, Vandenberghe P (2007) CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease. Leukemia 21:1451\u20131459","journal-title":"Leukemia"},{"key":"885_CR6","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.4049\/jimmunol.165.11.6606","volume":"165","author":"T Kouki","year":"2000","unstructured":"Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165:6606\u20136611","journal-title":"J Immunol"},{"key":"885_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00251-002-0429-9","volume":"54","author":"M M\u00e4urer","year":"2002","unstructured":"M\u00e4urer M, Loserth S, Kolb-M\u00e4urer A, Ponath A, Wiese S, Kruse N, Rieckmann P (2002) A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 54:1\u20138","journal-title":"Immunogenetics"},{"key":"885_CR8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","volume":"423","author":"H Ueda","year":"2003","unstructured":"Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I et al (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506\u2013511","journal-title":"Nature"},{"key":"885_CR9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.0105-2896.2005.00249.x","volume":"204","author":"SC Gough","year":"2005","unstructured":"Gough SC, Walker LS, Sansom DM (2005) CTLA4 gene polymorphism and autoimmunity. Immunol Rev 204:102\u2013115","journal-title":"Immunol Rev"},{"key":"885_CR10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-01-069781","volume":"110","author":"A P\u00e9rez-Garc\u00eda","year":"2007","unstructured":"P\u00e9rez-Garc\u00eda A, De la C\u00e1mara R, Rom\u00e1n-G\u00f3mez J, Jim\u00e9nez-Velasco A, Encuentra M, Nieto JB, de la Rubia J, Urbano-Ispiz\u00faa A, Brunet S, Iriondo A, Gonz\u00e1lez M, Serrano D, Espigado I, Solano C, Ribera JM, Pujal JM, Hoyos M, Gallardo D (2007) GVHD\/Immunotherapy Committee of the Spanish Group of Hematopoietic Stem Cell TransplantationCTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood 110:461\u2013467","journal-title":"Blood"},{"key":"885_CR11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1705850","volume":"40","author":"AM Vannucchi","year":"2007","unstructured":"Vannucchi AM, Guidi S, Guglielmelli P, Glinz S, Lombardini L, Busca A, Locatelli F, Dall'Omo AM, Bosi A (2007) Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation. Bone Marrow Transplant 40:1001\u20131002","journal-title":"Bone Marrow Transplant"},{"key":"885_CR12","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1182\/blood-2007-08-106385","volume":"110","author":"M Azarian","year":"2007","unstructured":"Azarian M, Busson M, Lepage V, Charron D, Toubert A, Loiseau P, de Latour RP, Rocha V, Soci\u00e9 G (2007) Donor CTLA-4 +49 A\/G*G\/G genotype is associated with chronic GvHD after HLA-identical haematopoietic stem-cell transplantations. Blood 110:4623\u20134624","journal-title":"Blood"},{"key":"885_CR13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2249.2007.03394.x","volume":"149","author":"G Balbi","year":"2007","unstructured":"Balbi G, Ferrera F, Rizzi M, Piccioli P, Morabito A, Cardamone L, Ghio M, Palmisano GL, Carrara P, Pedemonte S, Sessarego M, De Angioletti M, Notaro R, Indiveri F, Pistillo MP (2007) Association of -318 C\/T and +49 A\/G CTLA-4 gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis. Clin Exp Immunol 149:40\u201347","journal-title":"Clin Exp Immunol"},{"key":"885_CR14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1373\/clinchem.2007.095703","volume":"54","author":"P Piccioli","year":"2008","unstructured":"Piccioli P, Serra M, Pedemonte S, Balbi G, Loiacono F, Lastraioli S, Gargiulo L, Morabito A, Zuccaro D, Del Mastro L, Pistillo MP, Venturini M, De Angioletti M, Notaro R (2008) Hexa-primer amplification refractory mutation system PCR for the single tube simultaneous genotyping of two close polymorphisms. Clin Chem 54:227\u2013229","journal-title":"Clin Chem"},{"issue":"Suppl 1","key":"885_CR15","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1038\/sj.bmt.1704855","volume":"35","author":"J Svahn","year":"2005","unstructured":"Svahn J, Capasso M, Lanciotti M, Marrone A, Haupt R, Bacigalupo A, Pongiglione C, Boschetto L, Longoni D, Pillon M, Pistorio A, Di Michele P et al (2005) The polymorphisms -318C > T in the promoter and 49A > G in exon 1 of CTLA4 and the risk of aplastic anemia in a Caucasian population. Bone Marrow Transplant 35(Suppl 1):S89\u2013S92","journal-title":"Bone Marrow Transplant"},{"key":"885_CR16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/thy.2005.15.232","volume":"15","author":"A Petrone","year":"2005","unstructured":"Petrone A, Giorgi G, Galgani A, Alemanno I, Corsello SM, Signore A, Di Mario U, Nistic\u00f2 L, Cascino I, Buzzetti R (2005) CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid 15:232\u2013238","journal-title":"Thyroid"},{"key":"885_CR17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1182\/blood-2002-06-1668","volume":"101","author":"MP Pistillo","year":"2003","unstructured":"Pistillo MP, Tazzari PL, Palmisano GL, Pierri I, Bolognesi A, Ferlito F, Capanni P, Polito L, Ratta M, Pileri S, Piccioli M, Basso G, Rissotto L, Conte R, Gobbi M, Stirpe F, Ferrara GB (2003) CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. Blood 101:202\u2013209","journal-title":"Blood"},{"key":"885_CR18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2141.2006.06472.x","volume":"136","author":"S Laurent","year":"2007","unstructured":"Laurent S, Palmisano GL, Martelli AM, Kato T, Tazzari PL, Pierri I, Clavio M, Dozin B, Balbi G, Megna M, Morabito A, Lamparelli T, Bacigalupo A, Gobbi M, Pistillo MP (2007) CTLA-4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells can be targeted with ligands to induce apoptosis. Br J Haematol 136:597\u2013608","journal-title":"Br J Haematol"},{"key":"885_CR19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.0300-9475.2001.01019.x","volume":"55","author":"XB Wang","year":"2002","unstructured":"Wang XB, Giscombe R, Yan Z, Heiden T, Xu D, Lefvert AK (2002) Expression of CTLA-4 by human monocytes. Scand J Immunol 55:53\u201360","journal-title":"Scand J Immunol"},{"key":"885_CR20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bcmd.2007.08.004","volume":"40","author":"A Madrigal","year":"2008","unstructured":"Madrigal A, Shaw BE (2008) Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation. Blood Cells Mol Dis 40:40\u201343","journal-title":"Blood Cells Mol Dis"},{"key":"885_CR21","doi-asserted-by":"crossref","first-page":"46478","DOI":"10.1074\/jbc.M206894200","volume":"277","author":"S Anjos","year":"2002","unstructured":"Anjos S, Nguyen A, Ounissi-Benkalha H, Tessier MC, Polychronakos C (2002) A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 277:46478\u201346486","journal-title":"J Biol Chem"},{"key":"885_CR22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","volume":"23","author":"RJ Greenwald","year":"2005","unstructured":"Greenwald RJ, Freeman GJ, Sharpe AH (2005) The B7 family revisited. Annu Rev Immunol 23:515\u2013548","journal-title":"Annu Rev Immunol"},{"key":"885_CR23","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1182\/blood-2008-07-168468","volume":"113","author":"A Bashey","year":"2009","unstructured":"Bashey A, Medina B, Corringham S, Pasek M, Carrier E, Vrooman L, Lowy I, Solomon SR, Morris LE, Holland HK, Mason JR, Alyea EP, Soiffer RJ, Ball ED (2009) CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation. Blood 113:1581\u20131588","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0885-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-009-0885-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0885-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:50:10Z","timestamp":1559037010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-009-0885-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,18]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["885"],"URL":"https:\/\/doi.org\/10.1007\/s00277-009-0885-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,18]]}}}